New shot targets five strains of deadly meningitis
NCT ID NCT07374510
Summary
This is an early-stage study to test the safety and immune response of a new meningitis vaccine. The vaccine is designed to protect against five strains (A, C, Y, W135, and X) of meningococcal bacteria, which can cause serious brain and spinal cord infections. The study will enroll 150 healthy volunteers between the ages of 2 and 59 to see how their bodies react to the shot.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL MENINGITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.